Bank of New York Mellon’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-65,404
Closed -$45.9K 4309
2024
Q1
$45.9K Sell
65,404
-9,776
-13% -$11K ﹤0.01% 4088
2023
Q4
$132K Buy
75,180
+34,710
+86% +$50.7K ﹤0.01% 4039
2023
Q3
$58.3K Sell
40,470
-796
-2% -$1.99K ﹤0.01% 4149
2023
Q2
$107K Sell
41,266
-213
-0.5% -$637 ﹤0.01% 4078
2023
Q1
$153K Hold
41,479
﹤0.01% 3995
2022
Q4
$73.4K Buy
41,479
+29,327
+241% +$78K ﹤0.01% 4174
2022
Q3
$48K Sell
12,152
-3,995
-25% -$24.6K ﹤0.01% 4331
2022
Q2
$90K Sell
16,147
-62,374
-79% -$511K ﹤0.01% 4246
2022
Q1
$1.15M Sell
78,521
-2,944
-4% -$39.4K ﹤0.01% 3224
2021
Q4
$1.29M Sell
81,465
-18,783
-19% -$451K ﹤0.01% 3240
2021
Q3
$3.22M Buy
100,248
+10,927
+12% +$384K ﹤0.01% 2728
2021
Q2
$3.71M Buy
89,321
+39,001
+78% +$1.6M ﹤0.01% 2638
2021
Q1
$2.56M Buy
50,320
+19,398
+63% +$1.01M ﹤0.01% 2779
2020
Q4
$1M Buy
30,922
+6,896
+29% +$97.8K ﹤0.01% 3254
2020
Q3
$286K Buy
24,026
+5,937
+33% +$68.8K ﹤0.01% 3737
2020
Q2
$240K Buy
+18,089
New +$236K ﹤0.01% 3752

Other funds holding DMTK

Bank of New York Mellon's DMTK Position: Q2 2024 in Review

Bank of New York Mellon sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 65,404 shares — an estimated $45.9K sold.

Bank of New York Mellon first reported a position in DMTK in Q2 2020 and held it in 16 quarters. The position peaked at $3.71M in Q2 2021. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • Bank of New York Mellon reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 65,404 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $45.9K.
  • Bank of New York Mellon first reported a position in DermTech, Inc. Common Stock in Q2 2020 and held it in 16 quarters.
  • Bank of New York Mellon's DermTech, Inc. Common Stock position peaked at $3.71M in Q2 2021.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Bank of New York Mellon's 13F filing for Q2 2024, filed 25 Jul 2024.